References
- (Rob) Aggarwal S. What’s fueling the biotech engine—2012 to 2013. Nat Biotechnol. 2014;32:32–39.
- Craik DJ, Fairlie DP, Liras S, et al. The future of peptide-based drugs. Chem Biol Drug Des. 2013;81:136–147.
- Baeshen NA, Baeshen MN, Sheikh A, et al. Cell factories for insulin production. Microb Cell Factories. 2014;13:141.
- Rader RA, Langer ES. Biopharmaceutical manufacturing: historical and future trends in titers, yields, and efficiency in commercial-scale bioprocessing. BioProcessing. 2014;13:47–154.
- Pardee K, Green AA, Ferrante T, et al. Paper-based synthetic gene networks. Cell. 2014;159:940–954.
- Hu SX, Aitken ML, Epstein AM, et al. Market watch: defining and quantifying the use of personalized medicines. Nat Rev Drug Discov. 2013;12:896–897.
- Shimizu Y, Inoue A, Tomari Y, et al. Cell-free translation reconstituted with purified components. Nat Biotechnol. 2001;19:751–755.
- Zhang Y-HP. Production of biocommodities and bioelectricity by cell-free synthetic enzymatic pathway biotransformations: challenges and opportunities. Biotechnol Bioeng. 2010;105:663–677.
- Sachse R, Wüstenhagen D, Šamalíková M, et al. Synthesis of membrane proteins in eukaryotic cell-free systems. Eng Life Sci. 2013;13:39–48.
- Bujara M, Schümperli M, Pellaux R, et al. Optimization of a blueprint for in vitro glycolysis by metabolic real-time analysis. Nat Chem Biol. 2011;7:271–277.
- Dudley QM, Karim AS, Jewett MC. Cell-free metabolic engineering: biomanufacturing beyond the cell. Biotechnol J. 2015;10:69–82.
- Hong SH, Kwon Y-C, Martin RW, et al. Improving cell-free protein synthesis through genome engineering of escherichia coli lacking release factor 1. Chembiochem Eur J Chem Biol. 2015;16:844–853.
- Jewett MC, Swartz JR. Mimicking the Escherichia coli cytoplasmic environment activates long-lived and efficient cell-free protein synthesis. Biotechnol Bioeng. 2004;86:19–26 .
- Wang HH, Huang P-Y, Xu G, et al. Multiplexed in vivo his-tagging of enzyme pathways for in vitro single-pot multienzyme catalysis. ACS Synth Biol. 2012;1:43–52.
- Timm AC, Shankles PG, Foster CM, et al. Toward microfluidic reactors for cell-free protein synthesis at the point-of-care. Small. 2016;12:810–817.
- Caschera F, Noireaux V. Synthesis of 2.3 mg/ml of protein with an all Escherichia coli cell-free transcription–translation system. Biochimie. 2014;99:162–168.
- Millet LJ, Lucheon JD, Standaert RF, et al. Modular microfluidics for point-of-care protein purifications. Lab Chip. 2015;15:1799–1811.
- Gubala V, Harris LF, Ricco AJ, et al. Point of care diagnostics: status and future. Anal Chem. 2012;84:487–515.
- Rollin JA, del Campo JM, Myung S, et al. High-yield hydrogen production from biomass by in vitro metabolic engineering: mixed sugars coutilization and kinetic modeling. Proc Natl Acad Sci. 2015;112:4964–4969.
- Katzen F, Chang G, Kudlicki W. The past, present and future of cell-free protein synthesis. Trends Biotechnol. 2005;23:150–156.
- Goshima N, Kawamura Y, Fukumoto A, et al. Human protein factory for converting the transcriptome into an in vitro-expressed proteome. Nat Methods. 2008;5:1011–1017.
- Harrer S, Kim SC, Schieber C, et al. Label-free screening of single biomolecules through resistive pulse sensing technology for precision medicine applications. Nanotechnology. 2015;26:182502.